← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2012Last known activity
Apr 30, 2026
Timeline
2010s
- Jan 1, 2012
MedSIR— Founded
Drugs by trial phase (61 distinct, 50 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (58 own, 0 via acquisition)
Indications
Studied for
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Endometrioid
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Endometrial Neoplasms
- Lung Neoplasms
- Neoplasm Metastasis
- Neoplasms, Second Primary
- Penile Neoplasms
- Pneumonia
- Pneumonia, Viral
- Prostatic Neoplasms
- Small Cell Lung Carcinoma
- Triple Negative Breast Neoplasms
Recent trials (50)
- NCT07178938Lead sponsorPhase 2Apr 30, 2026
- NCT07134556Lead sponsorPhase 2Dec 8, 2025
- NCT07195227Lead sponsorPhase 2Dec 1, 2025
- NCT06676917Lead sponsorPhase 2Apr 30, 2025
- NCT06604858Lead sponsorPhase 2Feb 28, 2025
- NCT06612203Lead sponsorPhase 1/Phase 2Jan 31, 2025
- NCT06486883Lead sponsorPhase 2Dec 31, 2024
- NCT06315010Lead sponsorPhase 2Nov 30, 2024
- NCT06382948Lead sponsorPhase 3Sep 1, 2024
- NCT06172127Lead sponsorPhase 2May 31, 2024
- NCT06048718Lead sponsorPhase 2Dec 31, 2023
- NCT06180356Lead sponsorPhase 2Dec 31, 2023
- NCT05865990Lead sponsorPhase 2Sep 30, 2023
- NCT05708235Lead sponsorPhase 2Sep 30, 2023
- NCT05715229CollaboratorPhase 2Sep 29, 2023
Details
- Founded
- Barcelona, ES Jan 1, 2012
- Last known activity
- Apr 30, 2026